U.S. Markets close in 2 hrs 13 mins

Allergan’s Q3 2018 Estimates: Revenue Decline Expected

Mike Benson
Allergan’s Q3 2018 Estimates: Revenue Decline Expected

Analysts are estimating that Allergan’s (AGN) third-quarter revenues will decrease 3.8% to $3.88 billion. Allergan has classified its business operations into three business segments: US Specialized Therapeutics US General Medicine International